First in the Baltics: Northway Biotech opens €61 million cell therapy and personalized medicine CDMO in Vilnius
Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m [..]